Friday, 16 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

16:42 IST BSE
Fund RaiseNilkamal Ltd NILKAMAL

Nilkamal Fund Raise of ₹49 Cr

Nilkamal Limited confirmed full utilization of ₹49 Crore raised via Non-Convertible Debentures. There were no deviations from stated objects for the quarter ended March 2026.

Value
₹49.00 Cr
16:41 IST BSE
Annual General MeetingAMIC Forging Ltd 544037

AMIC Forging Annual General Meeting

Amic Forgings Limited convened an EGM for June 5, 2026, to approve a ₹220.99 Crore preferential fundraise. The capital will fund Phase-III expansion and general corporate needs.

Value
₹221.0 Cr
16:41 IST BSE
Results UpdateJSW Steel Ltd JSWSTEEL

JSW Steel Results Update

JSW Steel reported ₹51,180 Crore revenue for Q4 FY26. The company highlights significant deleveraging and a 5mtpa expansion approval, signaling robust growth and improved financial health.

Value
₹51,180 Cr
16:40 IST BSE
Legal & RegulatoryMeyer Apparel Ltd GIVO

Meyer Apparel Legal & Regulatory

Meyer Apparel Ltd settled decade-old material litigations without admitting liability. The settlement aims to save costs and management time, impacting June 2026 quarter results.

16:38 IST BSE
Financial ResultsGlobal Health Ltd MEDANTA

Global Health Financial Results

Global Health Limited approved audited FY26 results and recommended a Rs. 0.50 per share final dividend. New leadership appointments were also confirmed to drive growth.

Value
₹0.50 Cr
16:37 IST BSE
Fund RaiseLCC Infotech Ltd LCCINFOTEC

LCC Infotech Fund Raise of ₹42.55 Cr

LCC Infotech reported full utilization of ₹42.55 Crore raised via preferential issues. The Monitoring Agency confirmed funds were deployed as per stated object documents.

Value
₹42.55 Cr
16:29 IST BSE
Financial ResultsChemcrux Enterprises Ltd CHEMCRUX

Chemcrux Enterprises Financial Results

Chemcrux Enterprises reported standalone annual revenue of ₹82.58 Crore for FY2025-26. The Board recommended a 10% final dividend, reflecting steady financial performance and shareholder returns.

Value
₹82.57 Cr
16:28 IST BSE
Fund RaiseOrchid Pharma Ltd ORCHPHARMA

Orchid Pharma Fund Raise of ₹400 Cr

Orchid Pharma Limited submitted its Monitoring Agency Report for the Rs. 400 Crore QIP. The funds are being utilized as per revised shareholder-approved objects.

Value
₹400.0 Cr
16:28 IST BSE
Earnings CallMetropolis Healthcare Ltd METROPOLIS

Metropolis Healthcare Earnings Call: Key Takeaways

Metropolis Healthcare shows strong organic momentum, beating FY26 revenue guidance. Management is shifting focus from aggressive lab expansion to productivity-led growth and margin recovery through operating leverage.